Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05865470 · ClinicalTrials.gov registry record · Phase 1
Age-dependent Effects of Smoked and Oral Delta-9-THC
A Phase 1 study of Pain and Abuse, Drug, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT05865470: Recruiting Phase 1 study of Pain and Abuse, Drug, sponsored by University of California, Los Angeles.
NCT05865470 is a Phase 1 study of Pain and Abuse, Drug that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 103 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05865470, a Phase 1 study of Pain and Abuse, Drug, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.
Primary Outcome
Average and peak subjective ratings of drug effects associated with abuse liability and intoxication as measured using visual analogue scales (VAS; 1-100mm).
Conditions Studied
Interventions
- DRUG Oral Placebo
- DRUG Dronabinol
- DRUG Cannabis
- DRUG Smoked Placebo
Study Locations (1)
California
- UCLA Center for Cannabis and Cannabinoids - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2025-04-30 |
| Est. Completion | 2029-10-15 |
| Phase | Phase 1 |
What NCT05865470 shows while recruiting
NCT05865470 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (66% lower).
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Oral Placebo is the first listed.
NCT05865470 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05865470 about?
NCT05865470 is a clinical study titled "Age-dependent Effects of Smoked and Oral Delta-9-THC". This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.
What is the current status of trial NCT05865470?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 103 participants. The study started on 2025-04-30. Estimated completion is 2029-10-15.
What conditions does trial NCT05865470 study?
This clinical trial studies the following conditions: Pain, Abuse, Drug, Intoxication; Cannabinoids.
What interventions are being tested in trial NCT05865470?
The interventions under investigation include: Oral Placebo (DRUG), Dronabinol (DRUG), Cannabis (DRUG), Smoked Placebo (DRUG).
Who is sponsoring clinical trial NCT05865470?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05865470 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05865470's enrollment target sits among peer trials
103 159th of 374 higher than 216 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
RECRUITING · Phase 1
-
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
RECRUITING · Phase 1
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
-
Phase 1 Study of SBS-147 in Healthy Adults
RECRUITING · Phase 1
-
Patient Controlled Administration of Liquid Acetaminophen
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI